Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism Syk inhibitors(Spleen tyrosine kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Peripheral T-Cell Lymphoma | Preclinical | United States | 23 Aug 2020 |





